Sandra van der Walt
Boehringer Ingelheim (Germany)(DE)Boehringer Ingelheim (China)(CN)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins, Heart Failure Treatment and Management
Most-Cited Works
- → Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: A randomized trial(2019)27 cited
- → Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin–angiotensin system inhibitors in type 2 diabetic patients with albuminuria(2018)10 cited
- → Author response for "Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: A randomized trial"(2019)